Sensorion
Sensorion is a France-based biopharmaceutical company focused on developing therapies for inner ear disorders. The company pursues programs to treat hearing and balance impairments, including SENS-401 for sudden sensorineural hearing loss and SENS-111 for acute unilateral vestibulopathy, with SENS-300 in preclinical development for inner ear protection. Sensorion conducts research and development to restore hearing and vestibular function and pursues collaboration opportunities, including a strategic partnership with Cochlear Limited to study combination therapies for cochlear implant patients.
Top Stages
1 past transactions
Koubachi
Acquisition in 2014
Koubachi AG is a Swiss company specializing in interactive plant care solutions, founded in 2009 and headquartered in Zurich. The company offers a range of products designed to assist users in caring for their plants effectively. Its flagship products include Wi-Fi Plant Sensors that measure soil moisture, temperature, and light intensity, providing users with notifications and tailored care advice based on the specific needs of their plants. Koubachi also provides a mobile application for iPhone and a web application that allows users to manage their plant data and adjust sensor settings. The company's mission is to enhance the way individuals interact with their plants, aiming to embed its technology in every household. Koubachi AG operates as a subsidiary of Husqvarna AB.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.